NCT03957057View on ClinicalTrials.gov

Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia

PHASE3CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

April 30, 2022

Study Completion Date

June 15, 2022

Conditions
Postpartum Anemia NosIron-deficiency
Interventions
DRUG

Iron Carboxymaltose

Intravenous iron carboxymaltose application

DRUG

Iron Isomaltoside

Inravenous iron isomaltoside application

DRUG

Ferrous sulphate

Oral ferrous sulphate application

Trial Locations (1)

1000

UMC Ljubljana, Ljubljana

All Listed Sponsors
lead

University Medical Centre Ljubljana

OTHER

NCT03957057 - Intravenous Iron Carboxymaltose, Isomaltoside and Oral Iron Sulphate for Postpartum Anemia | Biotech Hunter | Biotech Hunter